Back to Search
Start Over
Human rotavirus vaccine (RIX4414) efficacy in the first two years of life
- Source :
- Human Vaccines & Immunotherapeutics
- Publication Year :
- 2013
- Publisher :
- Informa UK Limited, 2013.
-
Abstract
- Rotaviruses (RV) are a major cause of severe gastroenteritis (GE) in children aged 10%. The number of unsolicited symptoms and SAEs reported was similar between both groups. Thirteen deaths (RIX4414 = 6; placebo = 7) occurred during the study. All SAEs and deaths in the RIX4414 group were considered unrelated to vaccination. Two oral doses of RIX4414 vaccine provided a substantial level of protection against severe RVGE in Chinese children during the first two years of life.
- Subjects :
- Male
safety
China
Pediatrics
medicine.medical_specialty
Drug-Related Side Effects and Adverse Reactions
efficacy
Immunology
Treatment outcome
Placebo-controlled study
Administration, Oral
Rotavirus gastroenteritis
Placebo
Rotavirus Infections
Placebos
RIX4414 vaccine
parasitic diseases
Human rotavirus
medicine
Humans
Immunology and Allergy
Guangxi Province
Pharmacology
business.industry
Incidence
Incidence (epidemiology)
Vaccination
Rotavirus Vaccines
Infant
RIX4414
Gastroenteritis
rotavirus gastroenteritis
Treatment Outcome
Female
business
Research Paper
Subjects
Details
- ISSN :
- 2164554X and 21645515
- Volume :
- 10
- Database :
- OpenAIRE
- Journal :
- Human Vaccines & Immunotherapeutics
- Accession number :
- edsair.doi.dedup.....962ec261dd4cf7a87db173552ae052b2
- Full Text :
- https://doi.org/10.4161/hv.26319